RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Karolinska Development Stock

Karolinska Development Liabilities 2024

Karolinska Development Liabilities

11.57 M SEK

Ticker

KDEV.ST

ISIN

SE0002190926

WKN

A0M84G

In 2024, Karolinska Development's total liabilities amounted to 11.57 M SEK, a 13.33% difference from the 10.21 M SEK total liabilities in the previous year.

Karolinska Development Aktienanalyse

What does Karolinska Development do?

Karolinska Development AB is a Swedish investment company focused on promoting innovative biotech companies and start-ups. The company was founded in 2003 by the government of the Stockholm region and Karolinska Institutet University. The business model of Karolinska Development is designed to make profitable investments in promising biotech companies. It specifically supports companies in the areas of cancer treatment, immunotherapy, cardiovascular diseases, as well as neurology and psychiatry. The company provides capital and expertise to turn promising innovations into successful products. Karolinska Development operates different divisions to fulfill this purpose, including Karolinska Development AB (parent company), Karolinska Development Life Science Venture AB (a specialized investment company), and Karolinska Development Management AB (portfolio management team). Karolinska Development has built a strong portfolio of companies developing innovative products and therapies. One example is Modus Therapeutics AB, which has developed a new therapy for the treatment of sickle cell anemia. Another example is Aprea AB, a developer of gene therapies for combating cancer using tumor cells and genetic sequencing. The company's history is marked by many successful investments and acquisitions. One example is the acquisition of BioChromix AB in 2012, which developed a new technology for rapid and precise diagnosis of infectious diseases. Karolinska Development also actively participates in supporting new start-ups and company formations to promote promising innovations. Karolinska Development AB plays an important role in the biotech industry and significantly supports research in drug development. Through its unique position as an investor and partner for innovative companies, Karolinska Development is a driving force in the field of biotechnology. The company's business field is characterized by high risk and requires strategic thinking and skillful maneuvering in the market. However, Karolinska Development has managed to build a solid foundation and establish itself as an important player in the biotech industry through targeted investments, acquisitions, and partnerships. In summary, Karolinska Development plays a vital role in the biotech industry in Sweden and worldwide. The company has produced many innovative companies and products through targeted investments and acquisitions, contributing to changing lives and combating diseases. With its unique position as an investor and partner for biotech companies, Karolinska Development is well-equipped to continue promoting new innovations and advancing drug development in the future. Karolinska Development ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Karolinska Development's Liabilities

Karolinska Development's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Karolinska Development's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Karolinska Development's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Karolinska Development's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Karolinska Development’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Karolinska Development stock

What is the level of liabilities of Karolinska Development this year?

Karolinska Development has a debt balance of 11.57 M SEK this year.

What were the liabilities of Karolinska Development compared to the previous year?

The liabilities of Karolinska Development have increased by 13.33% increased compared to the previous year.

What are the consequences of high debt for investors of Karolinska Development?

High liabilities can pose a risk for investors of Karolinska Development, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Karolinska Development?

Low liabilities mean that Karolinska Development has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Karolinska Development affect the company?

An increase in liabilities of Karolinska Development can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Karolinska Development affect the company?

A decrease in the liabilities of Karolinska Development can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Karolinska Development?

Some factors that can influence the liabilities of Karolinska Development include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Karolinska Development so important for investors?

The liabilities of Karolinska Development are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Karolinska Development take to modify the liabilities?

To change its liabilities, Karolinska Development can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Karolinska Development pay?

Over the past 12 months, Karolinska Development paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Karolinska Development is expected to pay a dividend of 0 SEK.

What is the dividend yield of Karolinska Development?

The current dividend yield of Karolinska Development is .

When does Karolinska Development pay dividends?

Karolinska Development pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Karolinska Development?

Karolinska Development paid dividends every year for the past 0 years.

What is the dividend of Karolinska Development?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Karolinska Development located?

Karolinska Development is assigned to the 'Health' sector.

Wann musste ich die Aktien von Karolinska Development kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Karolinska Development from 11/2/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/2/2024.

When did Karolinska Development pay the last dividend?

The last dividend was paid out on 11/2/2024.

What was the dividend of Karolinska Development in the year 2023?

In the year 2023, Karolinska Development distributed 0 SEK as dividends.

In which currency does Karolinska Development pay out the dividend?

The dividends of Karolinska Development are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Karolinska Development

Our stock analysis for Karolinska Development Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Karolinska Development Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.